394 related articles for article (PubMed ID: 27019088)
41. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
42. Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin.
Li J; Ni X; Zhou Z; Leong KW
J Am Chem Soc; 2003 Feb; 125(7):1788-95. PubMed ID: 12580604
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and drug release properties of poly(ethylene oxide) segmented polysulfone copolymers.
Gu X; Kuang Y; Guo X; Fang J; Ni Z
J Control Release; 2008 May; 127(3):267-72. PubMed ID: 18353482
[TBL] [Abstract][Full Text] [Related]
44. Control of medicine release from solid dispersion composed of the poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly(ethylene oxide).
Ozeki T; Yuasa H; Kanaya Y
J Control Release; 1999 Mar; 58(1):87-95. PubMed ID: 10021492
[TBL] [Abstract][Full Text] [Related]
45. Stearic acid and high molecular weight PEO as matrix for the highly water soluble metoprolol tartrate in continuous twin-screw melt granulation.
Monteyne T; Adriaensens P; Brouckaert D; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2016 Oct; 512(1):158-167. PubMed ID: 27452420
[TBL] [Abstract][Full Text] [Related]
46. Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.
Mazzarino L; Borsali R; Lemos-Senna E
J Pharm Sci; 2014 Nov; 103(11):3764-3771. PubMed ID: 25187001
[TBL] [Abstract][Full Text] [Related]
47. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
48. Solid-state NMR studies of pharmaceutical solids in polymer matrices.
Lubach JW; Padden BE; Winslow SL; Salsbury JS; Masters DB; Topp EM; Munson EJ
Anal Bioanal Chem; 2004 Mar; 378(6):1504-10. PubMed ID: 15214410
[TBL] [Abstract][Full Text] [Related]
49. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines.
Mašek J; Lubasová D; Lukáč R; Turánek-Knotigová P; Kulich P; Plocková J; Mašková E; Procházka L; Koudelka Š; Sasithorn N; Gombos J; Bartheldyová E; Hubatka F; Raška M; Miller AD; Turánek J
J Control Release; 2017 Mar; 249():183-195. PubMed ID: 27469472
[TBL] [Abstract][Full Text] [Related]
50. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
[TBL] [Abstract][Full Text] [Related]
51. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system.
Cappello B; De Rosa G; Giannini L; La Rotonda MI; Mensitieri G; Miro A; Quaglia F; Russo R
Int J Pharm; 2006 Aug; 319(1-2):63-70. PubMed ID: 16650700
[TBL] [Abstract][Full Text] [Related]
52. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
53. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
54. Applications of poly(ethylene oxide) in controlled release tablet systems: a review.
Ma L; Deng L; Chen J
Drug Dev Ind Pharm; 2014 Jul; 40(7):845-51. PubMed ID: 24001212
[TBL] [Abstract][Full Text] [Related]
55. Poly(L-lactide)-b-poly(ethylene oxide) copolymers with different arms: hydrophilicity, biodegradable nanoparticles, in vitro degradation, and drug-release behavior.
Liu Q; Cai C; Dong CM
J Biomed Mater Res A; 2009 Mar; 88(4):990-9. PubMed ID: 18384173
[TBL] [Abstract][Full Text] [Related]
56. In Vivo Evaluation of a PEO-Gellan Gum Semi-Interpenetrating Polymer Network for the Oral Delivery of Sulpiride.
Hoosain FG; Choonara YE; Kumar P; Tomar LK; Tyagi C; du Toit LC; Pillay V
AAPS PharmSciTech; 2017 Apr; 18(3):654-670. PubMed ID: 27184677
[TBL] [Abstract][Full Text] [Related]
57. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
58. Mucoadhesive polymers for buccal drug delivery.
Laffleur F
Drug Dev Ind Pharm; 2014 May; 40(5):591-8. PubMed ID: 24576266
[TBL] [Abstract][Full Text] [Related]
59. Properties and mechanisms of drug release from matrix tablets containing poly(ethylene oxide) and poly(acrylic acid) as release retardants.
Zhang F; Meng F; Lubach J; Koleng J; Watson NA
Eur J Pharm Biopharm; 2016 Aug; 105():97-105. PubMed ID: 27260202
[TBL] [Abstract][Full Text] [Related]
60. Hollow mesoporous silica nanoparticles-loaded ion-crosslinked bilayer films with excellent mechanical properties and high bioavailability for buccal delivery.
Wang S; Jiang L; Meng S; Liu C; Wang H; Gao Z; Guo J
Int J Pharm; 2022 Aug; 624():122056. PubMed ID: 35905934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
